We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Myovant submitted a separate new drug application for relugolix last month for women with heavy menstrual bleeding associated with uterine fibroids. Read More
The UK has authorized the use of the corticosteroid dexamethasone to reduce the risk of death in COVID-19 patients requiring ventilation or oxygen. Read More